Alexey A. Schulga
16/10 Miklukho Maklaya Street
Moscow, MOW 117997, Russian Federation
Moscow, MOW 117997, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Evaluation of Site-Specific Radioiodination of Anti-EGFR-Targeted DARPin E01 Using (4-Hydroxyphenyl)ethyl Maleimide.
Journal: International journal of molecular sciences
Published: July 01, 2026
The Use of Glycine-Containing Peptide-Based Chelators for Labeling with 99mTc Improves the Imaging Properties of EpCAM-Targeting Designed Ankyrin Repeat Ec1.
Journal: Molecular pharmaceutics
Published: March 04, 2026
Comparative Preclinical Evaluation of the Tumor-Targeting Properties of Radioiodine and Technetium-Labeled Designed Ankyrin Repeat Proteins for Imaging of Epidermal Growth Factor Receptor Expression in Malignant Tumors.
Journal: International journal of molecular sciences
Published: August 28, 2025
Targeting of Epithelial Cell Adhesion Molecule-Expressing Malignant Tumors Using an Albumin-Binding Domain-Fused Designed Ankyrin Repeat Protein: Effect of the Molecular Architecture.
Journal: International journal of molecular sciences
Published: March 29, 2025
Selection of the optimal chelator for labeling of DARPin Ec1 with gallium-68 for PET imaging of EpCAM expression.
Journal: EJNMMI radiopharmacy and chemistry
Published: March 10, 2025
Structural Basis of Activity of HER2-Targeting Construct Composed of DARPin G3 and Albumin-Binding Domains.
Journal: International journal of molecular sciences
Published: September 20, 2024
The Barnase-Barstar-based pre-targeting strategy for enhanced antitumor therapy in vivo.
Journal: Biochimie
Published: August 08, 2024
Phase I Clinical Evaluation of Designed Ankyrin Repeat Protein [99mTc]Tc(CO)3-(HE)3-Ec1 for Visualization of EpCAM-Expressing Lung Cancer.
Journal: Cancers
Published: July 05, 2024
Comparative Preclinical Evaluation of HYNIC-Modified Designed Ankyrin Repeat Proteins G3 for the 99mTc-Based Imaging of HER2-Expressing Malignant Tumors.
Journal: Molecular pharmaceutics
Published: April 01, 2024
Preclinical Evaluation of HER2-Targeting DARPin G3: Impact of Albumin-Binding Domain (ABD) Fusion.
Journal: International journal of molecular sciences
Published: March 07, 2024
Targeted Delivery of HSP70 to Tumor Cells via Supramolecular Complex Based on HER2-Specific DARPin9_29 and the Barnase:Barstar Pair.
Journal: Cells
Published: November 24, 2023
Last Updated: 09/26/2026